Bloomberg: The "extremely fervent period" emerges as small companies flock to the AI boom
BlockBeats news, on May 8, according to Bloomberg, a small pharmaceutical company, which was even at risk of being delisted from the Nasdaq stock trading platform, celebrated a new cancer treatment patent and rapidly transformed into an AI company within just two months. This move, to some extent (though only briefly), helped save its stock price.
The company is named Qualigen Therapeutics, and has now been renamed to a certain exchange, trading under the stock code AIXC. After the renaming, its stock price more than doubled in late September.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Deutsche Bank’s Daniel Ghali sees stronger gold demand and higher copper prices in 2027
Full Statement from Nvidia Regarding Jensen Huang's Resignation and Leadership Team Restructuring
On the 12th, the board of directors announced that Jensen Huang has resigned from his positions as President, CEO, and board member, effective immediately. Current Executive Vice President and CFO Colette Kress has agreed to serve as interim CEO. The board has initiated a formal search for a new CEO and will consider candidates both inside and outside the company. At the same time, the board has appointed Harvey C. Jones as its first-ever Chairman.
Crypto prices
More
